Stock 000518 JIANGSU SIHUAN BIOENGINEERING CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Jiangsu Sihuan Bioengineering Co., Ltd

Equities

000518

CNE0000001P8

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
2.29 CNY +1.78% Intraday chart for Jiangsu Sihuan Bioengineering Co., Ltd +7.01% -31.02%
Apr. 29 Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Jiangsu Sihuan Bioengineering Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Business Summary

JIANGSU SIHUAN BIOENGINEERING CO., LTD is a China-based company principally engaged in the research, development, manufacture and distribution of medicines and health supplements. The Company’s main products include interleukin, erythropoietin (EPO), granulocyte colony-stimulating factor (G-CSF), tablets, bulk drugs, infusion glass bottles, soft bag infusion, syrup and healthcare products, among others. The Company is also engaged in landscape engineering, maintenance projects, the sale of nursery stocks and other businesses. The Company distributes its products in domestic market and to overseas markets.

Number of employees: 250

Sales per Business

CNY in Million2021Weight2022Weight Delta
Medicine
95.8 %
291 83.0 % 259 95.8 % -11.15%
Forest
3.8 %
11 3.1 % 10 3.8 % -5.46%
Other
0.4 %
49 13.9 % 1 0.4 % -97.90%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
100.0 %
351 100.0 % 270 100.0 % -23.03%

Managers

Managers TitleAgeSince
Yu Guo CEO
 Chief Executive Officer 36 20-06-18
Hai Zhen Xu DFI
 Director of Finance/CFO 46 17-06-08

Members of the board

Members of the board TitleAgeSince
Yu Lu BRD
 Director/Board Member 49 23-06-25
Wei Liu BRD
 Director/Board Member 62 -
Xiao Li Gong BRD
 Director/Board Member 35 17-01-18
Yu Guo CEO
 Chief Executive Officer 36 20-06-18
Lei Wang CHM
 Chairman 43 20-05-05
Li Ke Xu BRD
 Director/Board Member 39 19-10-24
Liang Wei Wu BRD
 Director/Board Member 45 22-06-23
Jun Wen BRD
 Director/Board Member 53 21-12-29
Li Wang BRD
 Director/Board Member 44 23-06-25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,029,556,222 603,447,254 ( 58.61 %) 0 58.61 %

Shareholders

NameEquities%Valuation
Bosera Asset Management Co., Ltd.
0.0135 %
139,000 0.0135 % 50 581 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.000670 %
6,900 0.000670 % 2 511 ¥
Yinhua Fund Management Co., Ltd.
0.000573 %
5,900 0.000573 % 2 147 ¥
CICC Fund Management Ltd.
0.000039 %
400 0.000039 % 146 ¥

Company contact information

Jiangsu Sihuan Bioengineering Co., Ltd.

6 Zhongfang, Xinyu Road Xinqiao Town

214434, Wuxi

+

http://www.000518shsw.com
address Jiangsu Sihuan Bioengineering Co., Ltd(000518)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sector Biopharmaceuticals

1st Jan change Capi.
JIANGSU SIHUAN BIOENGINEERING CO., LTD Stock Jiangsu Sihuan Bioengineering Co., Ltd
-31.02% 326M
CSL LIMITED Stock CSL Limited
-3.79% 88.14B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.45% 40.51B
BIOGEN INC. Stock Biogen Inc.
-15.94% 31.67B
UCB Stock UCB
+52.66% 24.62B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-14.50% 15.65B
INCYTE CORPORATION Stock Incyte Corporation
-14.38% 12.07B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.12% 11.97B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.56% 11.61B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.87% 8.81B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 000518 Stock
  4. Company Jiangsu Sihuan Bioengineering Co., Ltd